Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Hemodialysis patients~* Age greater than or equal to 18~* Able and willing to give informed consent~* Undetectable Anti-HBs Ab level~Exclusion Criteria:~* Presence of hepatitis BsAg, hepatitis BcAb~* Treatment with IVIg (intravenous immune globulin) within the last 6 months~* Hypersensitivity to components of either vaccine~* Contraindication to intramuscular injections

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).